# PENG Block for Total Hip Arthroplasty

> **NCT05944380** · PHASE4 · COMPLETED · sponsor: **Poznan University of Medical Sciences** · enrollment: 556 (actual)

## Conditions studied

- Hip Osteoarthritis
- Hip Arthropathy
- Hip Disease
- Hip Pain Chronic

## Interventions

- **DRUG:** Ropivacaine 0.5% Injectable Solution
- **DRUG:** 0,9% normal saline

## Key facts

- **NCT ID:** NCT05944380
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-16
- **Primary completion:** 2022-06-23
- **Final completion:** 2023-01-30
- **Target enrollment:** 556 (ACTUAL)
- **Last updated:** 2023-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05944380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05944380, "PENG Block for Total Hip Arthroplasty". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT05944380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*